查看購物車
  • English
  • Japanese
  • Korean
全球益生菌補充劑市場：按產品形式、分銷管道、最終用戶、健康應用、成分和地區分類－預測至2031年
市場調查報告書
商品編碼
2066266

全球益生菌補充劑市場：按產品形式、分銷管道、最終用戶、健康應用、成分和地區分類－預測至2031年

Probiotic Supplements Market by Product Form (Tablets, Capsules, Powder, Gummies & Chewable, Liquid, and Other Product Forms), Health Application, End User, Distribution Channel, Ingredient (Bacteria & Yeast), and Region - Global Forecast to 2031
出版日期: | 出版商: MarketsandMarkets | 英文 359 Pages | 訂單完成後即時交付

價格

益生菌補充劑市場預計將從 2026 年的 106 億美元成長到 2031 年的 166.9 億美元，複合年成長率高達 9.5%。

調查範圍
調查期 2022-2031
基準年 2025
預測期 2026-2031
計算單位 金額（100萬/10億美元）和數量（1000噸）
部分 按產品形式、分銷管道、最終用戶、健康用途、成分和地區分類。
目標區域 北美、歐洲、亞太地區、南美及其他地區

消費者對消化健康、腸道菌叢平衡、免疫支持和預防醫學的日益關注正在推動市場成長。對功能性營養產品的需求不斷增加，以及消費者對科學膳食補充劑的強烈需求，也促進了這一成長。

益生菌補充劑市場-IMG1

為了最佳化便利性、穩定性和針對性的健康功效，開發各種形式的新型益生菌製劑——膠囊、軟糖/咀嚼片、粉劑、片劑和液體——變得日益重要。同樣，對微生物組、菌株特異性製劑的投入增加，以及對經臨床檢驗的益生菌成分日益成長的關注，也進一步推動了該領域的創新。各公司也拓展產品線，以滿足包括胃腸道健康、免疫健康、女性健康、口腔健康、代謝健康和兒童健康在內的多種應用需求。

該市場面臨的挑戰包括監管方面的細微差異，例如有關健康聲明的法規、對活菌穩定性的擔憂，以及臨床試驗和菌株研發的高成本。然而，個人化營養的日益普及、電子通路的廣泛應用以及對功能性健康產品的需求，為全球益生菌補充劑生產商帶來了巨大的成長機會。

“按產品形式分類，預計軟糖和咀嚼片將在預測期內成為成長最快的細分市場。”

在預測期內，軟糖和咀嚼錠預計將成為益生菌補充劑市場中成長最快的產品劑型細分市場。由於消費者對易於消化且口味豐富的補充劑形式的需求不斷成長，益生菌軟糖和咀嚼片市場正經歷顯著成長。此類產品尤其受到兒童和青少年的歡迎。

近年來，許多公司都在研發益生菌軟糖配方，這些配方可能添加或不添加維生素和礦物質預混合料以及益生元，以支持與結構和功能相關的健康宣稱，例如支持消化器官系統和免疫系統。與傳統的膳食補充劑相比，這些配方具有許多優勢，例如口感更佳、更便於攜帶以及更容易堅持服用。

在益生菌補充劑市場，目前膠囊目前在所有機能性食品膠囊產品中佔據最大的市場佔有率。這是因為膠囊具有穩定性高、便於精準服用、保存期限長等優點，且大多數成年消費者都能輕鬆服用。膠囊的另一個優點在於，單次服用即可有效攝取多種益生菌菌株，因此適用於包括藥房、藥局和醫療保健管道在內的所有分銷管道。

“按健康用途分類，預計在預測期內，免疫支持類產品將成為成長最快的細分市場。”

在預測期內，免疫支持有望成為益生菌補充劑市場中成長最快的健康應用領域。消費者對免疫健康、預防醫學和健康管理意識的不斷提高，是推動消費者接受旨在支持免疫健康的益生菌補充劑的主要因素。

目前，越來越多的生產者正在研發採用經臨床驗證的細菌和酵母菌株的益生菌配方，以恢復腸道菌叢平衡並增強免疫反應。消費者對腸道健康影響免疫系統的認知不斷提高，也推動了對增強免疫力的益生菌補充劑的需求成長。

目前，消化器官系統健康領域在益生菌補充劑市場中佔最大佔有率，這主要得益於消費者對消化器官系統健康、腸內菌叢平衡和消化功能支持的日益重視。益生菌補充劑被各個年齡層的消費者廣泛用於促進消化功能、腸道健康和維持健康的腸內菌叢。

“按最終用戶細分市場來看，預計在預測期內，兒童細分市場將經歷最快的成長。”

在預測期內，兒童市場預計將成為益生菌補充劑市場成長最快的終端使用者群體。家長對兒童腸道健康、免疫力增強和消化健康的日益重視，正在推動兒童益生菌補充劑的消費。

如今，製造商們正將更多適口性好的口味和更容易服用的形式（例如軟糖、粉末、咀嚼片和滴劑）融入兒童益生菌產品中。人們對預防性小兒科的日益重視以及對其他以微生物組為中心的營養解決方案興趣的不斷成長，正在加速這一領域的發展。

目前，成人市場在益生菌補充劑市場中佔據最大佔有率，這主要得益於成人對旨在促進消化健康、免疫力代謝健康和進行一般預防保健的營養補充劑的高需求。工作人群健康意識的提高和日常保健補充劑使用量的增加，正在推動這一細分市場的成長。

“預計在預測期內，亞太地區將成為益生菌補充劑市場中成長最快的區域市場。”

在預測期內，亞太地區預計將成為益生菌補充劑市場中成長最快的區域市場，這主要得益於全部區域消費者對消化健康、免疫力支持和預防醫學的日益重視。可支配收入的增加、中產階級的壯大、快速的都市化以及飲食習慣的改變，都顯著推動了中國、印度、日本、韓國和澳洲等國家對益生菌補充劑的需求成長。

消費者對健康生活方式的日益重視，以及膠囊、軟糖、粉末、咀嚼片和液體等多種形式的益生菌產品的廣泛應用，顯著推動了亞太市場的擴張。機能性食品和膳食補充劑的日益普及、零售通路的不斷拓展以及電子商務的蓬勃發展，也共同促進了整個行業的成長。

此外，各公司正大力投資研發新產品、開發在地化配方並拓展通路，以提高其在當地社區的滲透率。同時，對預防醫學、小兒科、女性健康和個人化健康解決方案日益成長的關注，預計將在預測期內推動市場健康成長。

“按配銷通路分類，預計電子商務領域在預測期內將經歷最快的成長。”

在預測期內，電子商務有望成為益生菌補充劑市場中成長最快的銷售管道。產品日益數位化、健康相關產品線上購買量的激增以及消費者對便利性的需求，都在推動益生菌補充劑線上銷售的快速成長。

如今，消費者可以透過線上平台全天候存取更廣泛的產品選擇、訂閱選項、產品比較、客戶評價，甚至包括高階和限量版益生菌產品。製造商也擴大利用D2C（直接面對消費者）模式和數位行銷宣傳活動來提升其線上銷售業績。

由於消費者對藥局和藥局的高度信任、產品推薦以及臨床用益生菌的廣泛供應，藥局和藥局在益生菌補充劑市場佔據最大的市場佔有率。消費者持續表示會在藥局購買保健類益生菌，這得益於藥局和藥局的可靠性和信譽。

“按成分分類，預計布拉氏酵母菌部分在預測期內將經歷最快的成長。”

在預測期內，布氏酵母菌（Saccharomyces bradii）預計將成為益生菌補充劑市場中成長最快的成分類別。由於越來越多的科學研究證實其在改善消化器官系統和胃腸道健康以及治療抗生素相關消化器官系統疾病方面的有效性，因此對基於布氏酵母菌的益生菌補充劑的需求正在不斷成長。

由於其穩定性、活性以及與多種膳食補充劑形式的兼容性，布氏酵母菌（Saccharomyces bradii）正日益被生產商添加到旨在促進消化健康和增強免疫力的產品中。此外，隨著消費者對具有臨床驗證功效的特定益生菌菌株提出更高的精準度和有效性要求，各個細分市場都在不斷擴大。

目前，乳酸菌在益生菌補充劑市場中佔據了重要佔有率。這是因為乳酸菌的應用範圍極為廣泛，涵蓋消化系統健康、免疫系統健康、女性健康和整體健康等領域。此外，由於其廣泛的臨床支持、高度認可度以及膠囊、粉末、軟糖和液體等多種劑型，乳酸菌菌株成為益生菌補充劑配方中最常用的菌株。

市場上的主要參與者包括雀巢公司（瑞士）、養樂多本社（日本）、Symrise AG（德國）、Kerry Group plc（愛爾蘭）、康寶萊有限公司（英國）、森永乳業（日本）、安麗公司（英國）、Jarrow Formulas, Inc.和Biogaia（瑞典）。

調查範圍

本研究報告按產品形式（片劑、膠囊、粉末、軟糖/咀嚼片、液體和其他產品形式）、健康應用（消化器官系統健康、免疫支持、女性健康、代謝健康、腸道健康、口腔健康和其他健康應用）、最終用戶（嬰兒、兒童、成人和老年人）、配銷通路（大賣場/超級市場、藥局/藥局、專賣店、電子商務和其他分銷管道）、成分（細菌（乳酸桿菌、雙叉桿菌、芽孢桿菌、嗜熱鏈球菌）和酵母（布拉氏酵母菌和其他酵母））以及地區（北美、歐洲、亞太地區、南美和世界其他地區）分析了益生菌補充劑市場。

本報告深入分析了影響益生菌補充劑產業成長的關鍵因素，包括促進因素、阻礙因素、挑戰和機會。該報告對主要行業參與者進行了全面分析，深入剖析了他們的業務、服務、關鍵策略、協議、合作夥伴關係、新服務推出、併購以及與益生菌補充劑市場相關的最新動態。此外，該報告還對益生菌補充劑市場生態系統中新興的新創公司進行了競爭分析。該研究還涵蓋了行業特定趨勢，例如技術分析、生態系統和市場格局以及專利和監管環境。

購買本報告的理由

本報告為市場領導和新參與企業提供益生菌補充劑市場及其細分市場最準確的銷售額預測。這有助於相關人員了解競爭格局，獲得更深入的洞察，合理定位自身業務，並制定有效的打入市場策略。此外，本報告還幫助相關人員了解市場趨勢，並提供關鍵市場促進因素、限制因素、挑戰和機會的資訊。

本報告深入分析了以下幾點：

  • 分析影響益生菌補充劑市場成長的關鍵市場促進因素（消費者對消化健康和免疫力支持的意識不斷提高）、阻礙因素（與益生菌菌株相關的穩定性和保存期限挑戰）、機會（個性化營養和靶向益生菌配方的擴展）以及挑戰（管理多種益生菌菌株配方的複雜性）。
  • 產品開發/創新：深入了解益生菌補充劑市場的研發活動和新產品發布。
  • 市場發展：提供益生菌補充劑在各地區盈利市場分析的全面資訊。
  • 市場多元化：益生菌補充劑市場的新產品來源、未開發的市場、近期趨勢和投資的全面資訊。
  • 競爭分析：本分析涵蓋益生菌補充品市場的主要參與者，包括雀巢公司（瑞士）、養樂多本社（日本）、Symrise AG（德國）、Kerry Group plc（愛爾蘭）、康寶萊有限公司（英國）、森永乳業（英國）、安麗公司（英國）、Jarrow Formulas, Inc.（英國）、Biosmm, 英國 Plc（英國）、Nature's Way Products, LLC（英國）、Optibac Probiotics Ltd.（英國）、AB-BIOTICS SA（西班牙）、Lifeway Foods, Inc.（英國）以及益生菌補充劑市場的其他主要參與者。

目錄

第1章：引言

第2章執行摘要

第3章重要考察

第4章 市場概覽

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
    • 任務
  • 未滿足的需求和未開發的領域
  • 相互關聯的市場與跨產業機遇
  • 一級/二級/三級公司的策略性舉措

第5章 產業趨勢

  • 波特五力分析
  • 宏觀經濟展望
  • 供應鏈分析
  • 生態系分析
  • 價格分析
  • 貿易分析
  • 2026-2027 年主要會議和活動
  • 影響客戶業務的趨勢/顛覆性因素
  • 投資和資金籌措場景
  • 案例研究分析
  • 2025年美國關稅對益生菌補充劑市場的影響

第6章：技術進步、人工智慧的影響、專利、創新與未來應用

  • 主要技術
  • 互補技術
  • 鄰近技術
  • 技術藍圖
  • 專利分析
  • 未來應用
  • 人工智慧/生成式人工智慧對益生菌補充劑產業的影響
  • 成功案例和實際應用

第7章：監理情勢與永續性舉措

  • 當地法規和合規性
  • 對永續性的承諾
  • 監理政策對永續性舉措的影響

第8章：顧客趨勢與購買行為

  • 決策流程
  • 採購過程中的關鍵相關人員及其評估標準
  • 實施障礙和內部挑戰
  • 各個終端用戶產業尚未滿足的需求
  • 市場盈利

第9章：益生菌補充劑市場（以產品形式分類）

  • 片劑和軟膠囊
  • 膠囊
  • 粉末
  • 軟糖和咀嚼片
  • 液體
  • 其他

第10章：益生菌補充劑市場（按分銷管道分類）

  • 大賣場/超級市場
  • 藥局/藥局
  • 專賣店
  • 電子商務
  • 其他

第11章：益生菌補充劑市場（按最終用戶分類）

  • 嬰兒
  • 孩子
  • 成人
  • 老年人口

第12章：益生菌補充劑市場（依健康用途分類）

  • 消化器官系統健康
  • 免疫支持
  • 女性健康
  • 代謝健康
  • 口腔衛生
  • 其他

第13章：益生菌補充劑市場（按成分分類）

  • 細菌
  • 酵母菌

第14章：益生菌補充劑市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲和紐西蘭
    • 其他
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 其他地區
    • 中東
    • 非洲

第15章 競爭格局

  • 概述
  • 主要參與企業的策略/優勢，2020-2026 年
  • 2023-2025年收入分析
  • 2025年市佔率分析
  • 品牌對比
  • 企業估值矩陣：主要公司，2025 年
  • 公司估值矩陣：新創企業/中小企業，2025 年
  • 企業估值和財務指標
  • 競爭格局

第16章：公司簡介

  • 主要參與企業
    • NESTLE SA
    • YAKULT HONSHA CO., LTD.
    • BIOGAIA
    • KERRY GROUP PLC
    • AMWAY
    • NATURE'S WAY
    • HERBALIFE LTD.
    • MORINAGA MILK INDUSTRY CO., LTD.
    • JARROW FORMULAS, INC.
    • SYMRISE AG
    • METAGENICS, INC.
    • OPTIBIOTIX HEALTH PLC
    • OPTIBAC PROBIOTICS LTD.
    • AB-BIOTICS SA
    • LIFEWAY FOODS, INC.
  • 新創企業/中小企業
    • SEED HEALTH, INC.
    • PENDULUM THERAPEUTICS
    • FLORE INC.
    • CUSTOM PROBIOTICS INC.
    • ORA ORGANIC
    • LOVEBUG PROBIOTICS
    • BIOHM HEALTH
    • TONIIQ
    • FITBIOMICS
    • RESBIOTIC NUTRITION

第17章調查方法

第18章 鄰近及相關市場

第19章附錄

Product Code: FB 10527

The probiotic supplements market is projected to expand from USD 10.60 billion in 2026 to USD 16.69 billion by 2031, at a high CAGR of 9.5%.

Scope of the Report
Years Considered for the Study2022-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD Million/Billion) and Volume (KT)
SegmentsProduct Form, Health Application, End User, Distribution Channel, Ingredient, and Region
Regions coveredNorth America, Europe, Asia Pacific, South America, RoW

Consumer awareness of digestive health, microbiome balance, immune support, and preventive healthcare consumption is driving market growth. Increasing demand for functional nutrition products and a strong shift towards science-based dietary supplements are contributing to this growth.

Probiotic Supplements Market - IMG1

There is an increased emphasis on developing novel probiotic formulas across all format types, including capsules, gummies & chewable, powders, tablets, and liquids to optimize convenience, stability and targeted health claims. Likewise, a boost to microbiome investment, strain-specific formulations, and clinically validated probiotic ingredients is further driving product innovation in this space. Companies are also broadening their product ranges to support multiple applications such as gastrointestinal health, immune health, women's health, oral health, metabolic health and pediatric health.

Challenges in this market include regulatory nuances, such as stipulations on health claims, concerns about the stability of live organisms, and the high costs related to clinical trials and strain development. However, the increasing trend towards customized nutrition, the growing use of electronic channels, and the demand for functionally driven wellness products present significant growth opportunities for probiotic supplement manufacturers worldwide.

"By product form, gummies & chewables are expected to be the fastest-growing segment during the forecast period."

Gummies and chewables are expected to be the fastest-growing product form segment in the probiotic supplements market during the forecast period. The market for probiotic gummies and chewables has been experiencing significant growth due to rising consumer demand for easy-to-eat, flavored supplement forms. This category is especially favored by children and younger populations.

Recently, many companies have been developing probiotic gummy formulas with or without added vitamins and mineral premixes and prebiotics to support structure/function health claims such as digestive and immune system support. These formulas offer benefits such as improved mouthfeel, portability, and better compliance compared with traditional supplement forms.

Capsules currently have the largest market share among all functional food/capsule products in the probiotic supplements market. This is because capsules are highly stable, provide accurate dosing, have a longer shelf life, and are easy for most adult consumers to take. Successfully delivering multiple probiotic strains in a single dosage form is also an additional benefit of capsules, and hence their applicability across all channels of distribution, such as pharmacies, drugstores, and healthcare channels, among others.

"By health application, immunity support is expected to be the fastest-growing segment during the forecast period."

Immunity support is expected to be the fastest-growing health application segment in the probiotic supplements market during the forecast period. Rising consumer awareness of immune health, preventive healthcare, and wellness is a major factor fueling the acceptance of probiotic supplements designed to support immune health.

More manufacturers are now creating specialized probiotic formulations with clinically validated strains of bacteria and yeast to help restore the balance of the gut microbiome and achieve a stronger immune response. Growing consumer knowledge of the impact of gut health on the immune system is also driving an increased demand for probiotic supplements targeted at immunity.

Digestive health currently accounts for the largest share of the probiotic supplement market, driven by ever-increasing consumer awareness of digestive health, gut flora balance, and digestive support. Probiotic supplements are most commonly used to enhance digestion, intestinal health, and healthy gut flora across consumers of all age groups.

"By end user, the children segment is expected to witness the fastest growth during the forecast period."

Children are anticipated to be the fastest-growing end-user segment in the probiotic supplements market during the forecast period. Rising parental awareness about children's gut health, immunity building, and digestive health is boosting the consumption of probiotic supplements among children.

Manufacturers are now leveraging more pleasant taste profiles and more convenient administration forms (such as gummies, powders, chewables, and liquid drops) of child-friendly probiotics in the form of probiotic products. Rising awareness of preventive pediatrics, as well as other microbiome-centric nutrition solutions, has accelerated segment growth.

The application 'adults' now captures the largest market share in the probiotic supplements market on account of high consumption of dietary supplements targeted at digestive health, immune system boosting, metabolic health and general preventive healthcare. Increasing health consciousness and growing use of daily wellness supplements by working population segments are driving the segment growth.

"Asia Pacific is projected to be the fastest-growing regional market for probiotic supplements during the forecast period."

Asia Pacific is projected to be the fastest-growing regional market for probiotic supplements during the forecast period, owing to increasing consumer awareness regarding digestive wellness, immunity support, and preventive healthcare across the region. Rising disposable incomes, expanding middle-class population, rapid urbanization, and changing dietary habits are significantly contributing to the growing adoption of probiotic supplements in countries such as China, India, Japan, South Korea, and Australia.

Growing consumer inclination toward healthy lifestyles, leading to enhanced adoption of probiotic capsules, gummies, powders, chewable, and liquid formulae, is significantly contributing to the expansion of the Asia Pacific market. Increasing adoption of functional foods and dietary supplements, wider retail availability, and growing penetration of e-commerce sites are other factors adding to the overall industry growth.

In addition, companies are investing heavily in new product development, local formulations and broadening of distribution channels to increase their regional penetration. Additionally, rising emphasis on preventive care, pediatrics, women 's health and customized health solutions is anticipated to support healthy growth in the market over the forecast period.

"By distribution channel, the E-commerce segment is expected to witness the fastest growth during the forecast period."

E-commerce is expected to be the fastest-growing distribution channel segment of the probiotic supplements market during the forecast period. The rise in product digitization, the surge in online purchasing of health products, and consumers' inclination toward ease of shopping are supporting the rapid growth of online sales of probiotic supplements.

Consumers have more choices of products, subscription purchase options, product comparisons, customer reviews, and even 24/7 access to the most premium and limited-edition probiotic products through online platforms. Producers are increasingly using direct-to-consumer approaches and digital marketing campaigns to boost their success in online sales.

Pharmacies and drugstores have the largest market share in the probiotic supplements market due to high consumer trust, product recommendations, and the wide availability of probiotics positioned for clinical use. Customers continue to report buying health-related probiotics at the pharmacy, and this behavior is supported by the credibility and reliability of these retailers.

"By ingredient, the Saccharomyces boulardii segment is expected to witness the fastest growth during the forecast period."

Saccharomyces boulardii is expected to be the fastest-growing ingredient segment during the forecast period across the probiotic supplements market. Because there is more scientific research supporting the efficacy of Saccharomyces boulardii in managing digestive and gastrointestinal health and antibiotic-associated digestive disorders, the demand for Saccharomyces boulardii-based probiotic supplements is on the increase.

As a result of its stability, survivability and compatibility with a wide variety of supplement formats, Saccharomyces boulardii is being integrated into targeted digestive health and immunity support products by an increasing number of manufacturers. Segments are further expanding as consumers demand higher levels of accuracy and strength associated with specific probiotic strains that offer proven benefits according to clinical studies.

Lactobacilli represent the dominant segment of the probiotic supplements market currently. This is due to their presence in the largest number of applications, including digestive health, immune health, women 's health and general wellness. Moreover, strains of lactobacilli are the most utilized in probiotic supplement formulations because of the widespread clinical support, high awareness, and applications in capsule, powder, gummy and liquid formats.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the Probiotic supplements market.

  • By Company Type: Tier 1 - 30%, Tier 2 - 25%, and Tier 3 - 45%
  • By Designation: CXOs - 25%, Managers - 35%, Others - 40%
  • By Region: North America - 20%, Europe - 30%, Asia Pacific - 35%, South America - 10%, and Rest of the World -5%

Prominent companies in the market include Nestle S.A. (Switzerland), Yakult Honsha Co., Ltd. (Japan), Symrise AG (Germany), Kerry Group plc (Ireland), Herbalife Ltd. (UK), Morinaga Milk Industry Co., Ltd. (Japan), Amway Corporation (UK), Jarrow Formulas, Inc., Biogaia (Sweden), and others.

Research Coverage

This research report categorizes the probiotic supplements market by Product Form (Tablets, Capsules, Powder, Gummies & Chewable, Liquid, and Other Product Forms), Health Application (Digestive Health, Immunity Support, Women's Health, Metabolic Health, Gut Health, Oral Health, and Other Health Applications), End User (Infant, Children, Adults, and Geriatric Population), Distribution Channel (Hypermarkets/Supermarkets, Pharmacies/Drugstores, Specialty Stores, E-commerce, and Other Distribution Channel), Ingredient (Bacteria (Lactobacilli, Bifidobacterium, Bacillus, Streptococcus Thermophilus) and Yeast (Saccharomyces Boulardii, Other Yeasts)), and Region (North America, Europe, Asia Pacific, South America, and Rest of the World).

The report's scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, which influence the growth of the Probiotic supplements industry. A thorough analysis of the key industry players has been carried out to provide insights into their business, services, key strategies, contracts, partnerships, agreements, service launches, mergers & acquisitions, and recent developments associated with the Probiotic supplements market. This report provides a competitive analysis of emerging startups in the Probiotic supplements market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.

Reasons to Buy This Report

The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall Probiotic supplements and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

  • Analysis of key drivers (Increasing consumer awareness regarding digestive health and immunity support for Probiotic supplements), restraints (Stability and shelf-life challenges associated with probiotic strains), opportunities (Expansion of personalized nutrition and targeted probiotic formulations), and challenges (Managing formulation complexity across multiple probiotic strains), influencing the growth of the probiotic supplements market
  • Product Development/Innovation: Detailed insights into research & development activities and new product launches in the Probiotic supplements market
  • Market Development: Comprehensive information about the lucrative market analysis of probiotic supplements across varied regions
  • Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the Probiotic supplements market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Nestle S.A. (Switzerland), Yakult Honsha Co., Ltd. (Japan), Symrise AG (Germany), Kerry Group plc (Ireland), Herbalife Ltd. (UK), Morinaga Milk Industry Co., Ltd. (Japan), Amway Corporation (UK), Jarrow Formulas, Inc. (UK), BioGaia (Sweden), Metagenics, Inc. (UK), OptiBiotix Health Plc (UK), Nature's Way Products, LLC (UK), Optibac Probiotics Ltd. (UK), AB-BIOTICS S.A. (Spain), Lifeway Foods, Inc. (UK), and other players in the probiotic supplements market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE AND SEGMENTATION
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 STAKEHOLDERS

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN PROBIOTIC SUPPLEMENTS MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PROBIOTIC SUPPLEMENTS MARKET
  • 3.2 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM AND REGION
  • 3.3 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT
  • 3.4 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL
  • 3.5 PROBIOTIC SUPPLEMENTS MARKET, BY END USER
  • 3.6 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION
  • 3.7 PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising prevalence of digestive health disorders and gastrointestinal diseases
      • 4.2.1.2 Growing consumer focus on preventive healthcare and wellness
      • 4.2.1.3 Increasing scientific evidence supporting microbiome health benefits
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Regulatory complexities and health claim restrictions
      • 4.2.2.2 Stability and shelf-life challenges of live probiotic organisms
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Expansion of personalized nutrition and microbiome-based supplementation
      • 4.2.3.2 Innovation in delivery formats like gummies, chewables, and stick packs
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Scientific debate and inconsistent clinical outcomes across strains
      • 4.2.4.2 Regulatory restrictions on health claims and marketing communications
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN PROBIOTIC SUPPLEMENTS MARKET
      • 4.3.1.1 Improved probiotic survivability and delivery efficiency
      • 4.3.1.2 Cost-effective and scalable solutions for emerging markets
      • 4.3.1.3 Stronger clinical validation and healthcare adoption
    • 4.3.2 WHITE SPACE OPPORTUNITIES
      • 4.3.2.1 Women's microbiome and hormonal health solutions
      • 4.3.2.2 Postbiotic and next-generation microbiome products
      • 4.3.2.3 Probiotic supplements for mental wellness and the gut-brain axis
      • 4.3.2.4 Personalized digital microbiome ecosystems
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
    • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 BARGAINING POWER OF BUYERS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 THREAT OF NEW ENTRANTS
  • 5.2 MACROECONOMICS OUTLOOK
    • 5.2.1 RISING GLOBAL POPULATION AND INCREASING DEMAND FOR PREVENTIVE HEALTHCARE
    • 5.2.2 EXPANSION OF E-COMMERCE AND DIGITAL HEALTH ECOSYSTEMS
  • 5.3 SUPPLY CHAIN ANALYSIS
    • 5.3.1 UPSTREAM (RAW MATERIALS & INGREDIENT SUPPLIERS)
    • 5.3.2 INGREDIENT PROCESSING & MANUFACTURING
    • 5.3.3 SUPPLEMENT MANUFACTURING & FORMULATION
    • 5.3.4 DISTRIBUTION & COMMERCIALIZATION
    • 5.3.5 END USERS
    • 5.3.6 SUPPORTING ECOSYSTEM
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT FORM
    • 5.5.2 AVERAGE SELLING PRICE, BY REGION
  • 5.6 TRADE ANALYSIS
    • 5.6.1 IMPORT SCENARIO (HS CODE 300490)
    • 5.6.2 EXPORT SCENARIO (HS CODE 300490)
  • 5.7 KEY CONFERENCES AND EVENTS, 2026-2027
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.9 INVESTMENT AND FUNDING SCENARIO
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 PENDULUM THERAPEUTICS INTRODUCED GLUCOSE CONTROL PROBIOTIC FOR METABOLIC HEALTH
    • 5.10.2 NESTLE HEALTH SCIENCE LAUNCHED PERSONALIZED NUTRITION PLATFORM TO SUPPORT GUT HEALTH
  • 5.11 IMPACT OF 2025 US TARIFF - PROBIOTIC SUPPLEMENTS MARKET
    • 5.11.1 INTRODUCTION
    • 5.11.2 KEY TARIFF RATES
    • 5.11.3 PRICE IMPACT ANALYSIS
    • 5.11.4 IMPACT ON COUNTRIES/REGIONS
      • 5.11.4.1 US
      • 5.11.4.2 Europe
      • 5.11.4.3 Asia Pacific
    • 5.11.5 IMPACT ON END-USE INDUSTRIES
    • 5.11.6 US TARIFF UPDATE (2026) AND LEGAL DEVELOPMENTS

6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 KEY TECHNOLOGIES
    • 6.1.1 MICROENCAPSULATION
    • 6.1.2 GENOMIC & METAGENOMIC SEQUENCING
    • 6.1.3 LYOPHILIZATION (FREEZE-DRYING)
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 AI-DRIVEN PERSONALIZATION & DIGITAL HEALTH INTEGRATION
    • 6.2.2 COLD-CHAIN INNOVATION & ADVANCED STABILITY LOGISTICS
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 PRECISION FERMENTATION
    • 6.3.2 SYNTHETIC BIOLOGY & STRAIN ENGINEERING
  • 6.4 TECHNOLOGY ROADMAP
  • 6.5 PATENT ANALYSIS
    • 6.5.1 INTRODUCTION
    • 6.5.2 LIST OF MAJOR PATENTS, MARCH 2020-DECEMBER 2024
  • 6.6 FUTURE APPLICATIONS
    • 6.6.1 PERSONALIZED MICROBIOME-BASED NUTRITION
    • 6.6.2 MENTAL WELLNESS AND GUT-BRAIN HEALTH
    • 6.6.3 WOMEN'S HEALTH SOLUTIONS
    • 6.6.4 LIVE BIOTHERAPEUTIC PRODUCTS (LBPS)
    • 6.6.5 AI-ENABLED PERSONALIZED PROBIOTIC ECOSYSTEMS
  • 6.7 IMPACT OF AI/GEN AI ON PROBIOTIC SUPPLEMENTS INDUSTRY
    • 6.7.1 TOP USE CASES AND MARKET POTENTIALS
    • 6.7.2 BEST PRACTICES IN PROBIOTIC SUPPLEMENTS INDUSTRY
    • 6.7.3 CASE STUDIES RELATED TO AI IMPLEMENTATION IN PROBIOTIC SUPPLEMENTS MARKET
    • 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 6.7.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN PROBIOTIC SUPPLEMENTS MARKET
  • 6.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
    • 6.8.1 DSM-FIRMENICH: AI4B.IO FOR BIOSCIENCE INNOVATION
    • 6.8.2 NESTLE HEALTH SCIENCE: PERSONALIZED NUTRITION PLATFORM
    • 6.8.3 VIOME: AI-POWERED MICROBIOME PERSONALIZATION

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY FRAMEWORK
      • 7.1.1.1 North America
        • 7.1.1.1.1 US
        • 7.1.1.1.2 Canada
        • 7.1.1.1.3 Mexico
      • 7.1.1.2 Europe
        • 7.1.1.2.1 Germany
        • 7.1.1.2.2 UK
        • 7.1.1.2.3 France
        • 7.1.1.2.4 Italy
        • 7.1.1.2.5 Spain
        • 7.1.1.2.6 Rest of Europe
      • 7.1.1.3 Asia Pacific
        • 7.1.1.3.1 China
        • 7.1.1.3.2 India
        • 7.1.1.3.3 Japan
        • 7.1.1.3.4 South Korea
        • 7.1.1.3.5 Australia & New Zealand
        • 7.1.1.3.6 Rest of Asia Pacific
      • 7.1.1.4 South America
        • 7.1.1.4.1 Brazil
        • 7.1.1.4.2 Rest of South America
      • 7.1.1.5 RoW
        • 7.1.1.5.1 Middle East Region
        • 7.1.1.5.2 Africa Region
    • 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.3 INDUSTRY STANDARDS
    • 7.1.4 DOCUMENTATION REQUIREMENTS
    • 7.1.5 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
  • 7.2 SUSTAINABILITY INITIATIVES
  • 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
    • 7.3.1 CERTIFICATIONS, LABELING, ECO-STANDARDS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 8.5 MARKET PROFITABILITY
    • 8.5.1 REVENUE POTENTIAL
    • 8.5.2 COST DYNAMICS
    • 8.5.3 MARGIN OPPORTUNITIES, BY PRODUCT FORMAT

9 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM

  • 9.1 INTRODUCTION
  • 9.2 TABLETS & SOFTGELS
    • 9.2.1 CONVENIENT DOSAGE FORMAT SUPPORTING DEMAND FOR PROBIOTIC TABLET SUPPLEMENTS
  • 9.3 CAPSULES
    • 9.3.1 HIGH STABILITY AND STRAIN PROTECTION DRIVING DEMAND FOR PROBIOTIC CAPSULES
  • 9.4 POWDER
    • 9.4.1 FLEXIBLE DOSING AND PEDIATRIC APPLICATIONS DRIVING DEMAND FOR PROBIOTIC POWDER FORMULATIONS
  • 9.5 GUMMIES & CHEWABLES
    • 9.5.1 INCREASING FOCUS ON PALATABLE AND CONSUMER-FRIENDLY SUPPLEMENTS DRIVING GUMMY PROBIOTIC DEMAND
  • 9.6 LIQUID
    • 9.6.1 RAPID ABSORPTION AND PEDIATRIC SUITABILITY SUPPORTING DEMAND FOR LIQUID PROBIOTIC FORMULATIONS
  • 9.7 OTHER PRODUCT FORMS

10 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL

  • 10.1 INTRODUCTION
  • 10.2 HYPERMARKETS/SUPERMARKETS
    • 10.2.1 HIGH PRODUCT VISIBILITY AND CONSUMER ACCESSIBILITY SUPPORTING PROBIOTIC SALES THROUGH MODERN RETAIL CHANNELS
  • 10.3 PHARMACIES/DRUGSTORES
    • 10.3.1 STRONG CONSUMER TRUST AND HEALTHCARE-ORIENTED PURCHASING DRIVING PROBIOTIC SALES THROUGH PHARMACIES
  • 10.4 SPECIALTY STORES
    • 10.4.1 RISING POPULARITY OF PREMIUM AND TARGETED NUTRITION PRODUCTS DRIVING GROWTH OF SPECIALTY HEALTH STORES
  • 10.5 E-COMMERCE
    • 10.5.1 RAPID DIGITALIZATION AND ONLINE WELLNESS PURCHASING FUELING EXPANSION OF E-COMMERCE CHANNELS
  • 10.6 OTHER DISTRIBUTION CHANNELS

11 PROBIOTIC SUPPLEMENTS MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 INFANTS
    • 11.2.1 INCREASING FOCUS ON EARLY-LIFE MICROBIOME DEVELOPMENT DRIVING DEMAND FOR INFANT PROBIOTIC SUPPLEMENTS
  • 11.3 CHILDREN
    • 11.3.1 RISING PARENTAL AWARENESS REGARDING PEDIATRIC IMMUNITY AND DIGESTIVE WELLNESS DRIVING DEMAND FOR PROBIOTIC SUPPLEMENTS
  • 11.4 ADULTS
    • 11.4.1 INCREASING PREVALENCE OF LIFESTYLE-RELATED HEALTH CONDITIONS SUPPORTING ADULT PROBIOTIC CONSUMPTION
  • 11.5 GERIATRIC POPULATION
    • 11.5.1 GROWING AGING POPULATION AND DIGESTIVE HEALTH CONCERNS DRIVING DEMAND FOR PROBIOTIC SUPPLEMENTS AMONG GERIATRIC CONSUMERS

12 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION

  • 12.1 INTRODUCTION
  • 12.2 DIGESTIVE HEALTH
    • 12.2.1 GROWING PREVALENCE OF GASTROINTESTINAL DISORDERS SUPPORTING DEMAND FOR DIGESTIVE HEALTH PROBIOTIC SUPPLEMENTS
  • 12.3 IMMUNITY SUPPORT
    • 12.3.1 INCREASING FOCUS ON IMMUNE RESILIENCE DRIVING ADOPTION OF IMMUNITY SUPPORT PROBIOTIC SUPPLEMENTS
  • 12.4 WOMEN'S HEALTH
    • 12.4.1 RISING FOCUS ON VAGINAL, URINARY, AND HORMONAL WELLNESS DRIVING DEMAND FOR WOMEN'S HEALTH PROBIOTIC SUPPLEMENTS
  • 12.5 METABOLIC HEALTH
    • 12.5.1 RISING PREVALENCE OF OBESITY AND LIFESTYLE DISORDERS SUPPORTING DEMAND FOR METABOLIC HEALTH PROBIOTIC SUPPLEMENTS
  • 12.6 ORAL HEALTH
    • 12.6.1 RISING PREVALENCE OF DENTAL CARIES, GINGIVITIS, AND ORAL MICROBIOME IMBALANCE DRIVING DEMAND FOR ORAL HEALTH PROBIOTIC SUPPLEMENTS
  • 12.7 OTHER HEALTH APPLICATIONS

13 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT

  • 13.1 INTRODUCTION
  • 13.2 BACTERIA
    • 13.2.1 STRONG CLINICAL VALIDATION AND WIDESPREAD DIGESTIVE HEALTH APPLICATIONS SUPPORTING BACTERIAL PROBIOTIC DOMINANCE
    • 13.2.2 LACTOBACILLI
    • 13.2.3 BIFIDOBACTERIUM
    • 13.2.4 BACILLUS
    • 13.2.5 STREPTOCOCCUS THERMOPHILUS
  • 13.3 YEAST
    • 13.3.1 INCREASING UTILIZATION OF STABLE MICROORGANISM STRAINS SUPPORTING YEAST-BASED PROBIOTICS DEMAND
    • 13.3.2 SACCHAROMYCES BOULARDII
    • 13.3.3 OTHER YEASTS

14 PROBIOTIC SUPPLEMENTS MARKET, BY REGION

  • 14.1 INTRODUCTION
  • 14.2 NORTH AMERICA
    • 14.2.1 US
      • 14.2.1.1 Strong microbiome health awareness and high functional supplement adoption to drive market
    • 14.2.2 CANADA
      • 14.2.2.1 Growing functional food consumption and strong regulatory oversight to support market growth
    • 14.2.3 MEXICO
      • 14.2.3.1 Rising health awareness and expanding functional nutrition demand to support market development
  • 14.3 EUROPE
    • 14.3.1 GERMANY
      • 14.3.1.1 Strong dietary supplement industry and increasing preventive healthcare awareness to support market growth
    • 14.3.2 UK
      • 14.3.2.1 Expanding e-commerce healthcare retail and growing gut health awareness to drive market
    • 14.3.3 FRANCE
      • 14.3.3.1 Strong preventive healthcare culture and scientific engagement to support market expansion
    • 14.3.4 SPAIN
      • 14.3.4.1 Growing consumer awareness and increasing digestive health focus to support market growth
    • 14.3.5 ITALY
      • 14.3.5.1 High consumer familiarity with probiotics and strong pharmacy distribution channels to support market expansion
    • 14.3.6 REST OF EUROPE
  • 14.4 ASIA PACIFIC
    • 14.4.1 CHINA
      • 14.4.1.1 Growing digestive health awareness and expanding nutraceutical industry to drive market
    • 14.4.2 JAPAN
      • 14.4.2.1 High consumer awareness regarding gut health and strong healthy aging demand to support market expansion
    • 14.4.3 SOUTH KOREA
      • 14.4.3.1 Strong functional nutrition culture and expanding online supplement sales to support market growth
    • 14.4.4 INDIA
      • 14.4.4.1 Rising digestive health concerns and expanding nutraceutical industry to drive market
    • 14.4.5 AUSTRALIA & NEW ZEALAND
      • 14.4.5.1 Strong preventive healthcare culture and high supplement consumption to support market expansion
    • 14.4.6 REST OF ASIA PACIFIC
  • 14.5 SOUTH AMERICA
    • 14.5.1 BRAZIL
      • 14.5.1.1 Large consumer base, expanding dietary supplement industry, and rising gut health awareness to support market growth
    • 14.5.2 ARGENTINA
      • 14.5.2.1 Increasing healthcare awareness and growing preventive nutrition adoption to support market expansion
    • 14.5.3 REST OF SOUTH AMERICA
  • 14.6 REST OF THE WORLD
    • 14.6.1 MIDDLE EAST
      • 14.6.1.1 High healthcare expenditure, rising lifestyle-related diseases, and growing wellness consumption to drive market
    • 14.6.2 AFRICA
      • 14.6.2.1 Rising healthcare awareness, growing digestive health concerns, and expanding pharmacy retail infrastructure to drive market

15 COMPETITIVE LANDSCAPE

  • 15.1 OVERVIEW
  • 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2026
  • 15.3 REVENUE ANALYSIS, 2023-2025
  • 15.4 MARKET SHARE ANALYSIS, 2025
  • 15.5 BRAND COMPARISON
  • 15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 15.6.1 STARS
    • 15.6.2 EMERGING LEADERS
    • 15.6.3 PERVASIVE PLAYERS
    • 15.6.4 PARTICIPANTS
    • 15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 15.6.5.1 Company footprint
      • 15.6.5.2 Region footprint
      • 15.6.5.3 Health application footprint
      • 15.6.5.4 Product form footprint
      • 15.6.5.5 End user footprint
  • 15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 15.7.1 PROGRESSIVE COMPANIES
    • 15.7.2 RESPONSIVE COMPANIES
    • 15.7.3 DYNAMIC COMPANIES
    • 15.7.4 STARTING BLOCKS
    • 15.7.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2025
      • 15.7.5.1 Detailed list of key startups/SMEs
      • 15.7.5.2 Competitive benchmarking of key startups/SMEs
  • 15.8 COMPANY VALUATION AND FINANCIAL METRICS
    • 15.8.1 COMPANY VALUATION
    • 15.8.2 EV/EBITDA
  • 15.9 COMPETITIVE SCENARIO
    • 15.9.1 PRODUCT LAUNCHES
    • 15.9.2 DEALS
    • 15.9.3 EXPANSIONS

16 COMPANY PROFILES

  • 16.1 KEY PLAYERS
    • 16.1.1 NESTLE S.A.
      • 16.1.1.1 Business overview
      • 16.1.1.2 Products/Solutions/Services offered
      • 16.1.1.3 Recent developments
        • 16.1.1.3.1 Deals
      • 16.1.1.4 MnM view
        • 16.1.1.4.1 Right to win
        • 16.1.1.4.2 Strategic choices
        • 16.1.1.4.3 Weaknesses and competitive threats
    • 16.1.2 YAKULT HONSHA CO., LTD.
      • 16.1.2.1 Business overview
      • 16.1.2.2 Products/Solutions/Services offered
      • 16.1.2.3 Recent developments
        • 16.1.2.3.1 Product launches
        • 16.1.2.3.2 Deals
      • 16.1.2.4 MnM view
        • 16.1.2.4.1 Right to win
        • 16.1.2.4.2 Strategic choices
        • 16.1.2.4.3 Weaknesses and competitive threats
    • 16.1.3 BIOGAIA
      • 16.1.3.1 Business overview
      • 16.1.3.2 Products/Solutions/Services offered
      • 16.1.3.3 Recent developments
        • 16.1.3.3.1 Product launches
        • 16.1.3.3.2 Deals
      • 16.1.3.4 MnM view
        • 16.1.3.4.1 Right to win
        • 16.1.3.4.2 Strategic choices
        • 16.1.3.4.3 Weaknesses and competitive threats
    • 16.1.4 KERRY GROUP PLC
      • 16.1.4.1 Business overview
      • 16.1.4.2 Products/Solutions/Services offered
      • 16.1.4.3 Recent developments
        • 16.1.4.3.1 Deals
      • 16.1.4.4 MnM view
        • 16.1.4.4.1 Right to win
        • 16.1.4.4.2 Strategic choices
        • 16.1.4.4.3 Weaknesses and competitive threats
    • 16.1.5 AMWAY
      • 16.1.5.1 Business overview
      • 16.1.5.2 Products/Solutions/Services offered
      • 16.1.5.3 Recent developments
        • 16.1.5.3.1 Product launches
      • 16.1.5.4 MnM view
        • 16.1.5.4.1 Right to win
        • 16.1.5.4.2 Strategic choices
        • 16.1.5.4.3 Weaknesses and competitive threats
    • 16.1.6 NATURE'S WAY
      • 16.1.6.1 Business overview
      • 16.1.6.2 Products/Solutions/Services offered
      • 16.1.6.3 Recent developments
        • 16.1.6.3.1 Expansions
      • 16.1.6.4 MnM view
    • 16.1.7 HERBALIFE LTD.
      • 16.1.7.1 Business overview
      • 16.1.7.2 Products/Solutions/Services offered
      • 16.1.7.3 Recent developments
        • 16.1.7.3.1 Deals
      • 16.1.7.4 MnM view
    • 16.1.8 MORINAGA MILK INDUSTRY CO., LTD.
      • 16.1.8.1 Business overview
      • 16.1.8.2 Products/Solutions/Services offered
      • 16.1.8.3 Recent developments
        • 16.1.8.3.1 Deals
      • 16.1.8.4 MnM view
    • 16.1.9 JARROW FORMULAS, INC.
      • 16.1.9.1 Business overview
      • 16.1.9.2 Products/Solutions/Services offered
      • 16.1.9.3 Recent developments
        • 16.1.9.3.1 Product launches
        • 16.1.9.3.2 Deals
      • 16.1.9.4 MnM view
    • 16.1.10 SYMRISE AG
      • 16.1.10.1 Business overview
      • 16.1.10.2 Products/Solutions/Services offered
      • 16.1.10.3 Recent developments
        • 16.1.10.3.1 Product launches
      • 16.1.10.4 MnM view
    • 16.1.11 METAGENICS, INC.
      • 16.1.11.1 Business overview
      • 16.1.11.2 Products/Solutions/Services offered
      • 16.1.11.3 Recent developments
        • 16.1.11.3.1 Deals
      • 16.1.11.4 MnM view
    • 16.1.12 OPTIBIOTIX HEALTH PLC
      • 16.1.12.1 Business overview
      • 16.1.12.2 Products/Solutions/Services offered
      • 16.1.12.3 Recent developments
      • 16.1.12.4 MnM view
    • 16.1.13 OPTIBAC PROBIOTICS LTD.
      • 16.1.13.1 Business overview
      • 16.1.13.2 Products/Solutions/Services offered
      • 16.1.13.3 Recent developments
        • 16.1.13.3.1 Product launches
      • 16.1.13.4 MnM view
    • 16.1.14 AB-BIOTICS S.A.
      • 16.1.14.1 Business overview
      • 16.1.14.2 Products/Solutions/Services offered
      • 16.1.14.3 Recent developments
        • 16.1.14.3.1 Deals
      • 16.1.14.4 MnM view
    • 16.1.15 LIFEWAY FOODS, INC.
      • 16.1.15.1 Business overview
      • 16.1.15.2 Products/Solutions/Services offered
      • 16.1.15.3 Recent developments
      • 16.1.15.4 MnM view
  • 16.2 STARTUPS/SMES
    • 16.2.1 SEED HEALTH, INC.
      • 16.2.1.1 Business overview
      • 16.2.1.2 Products/Solutions/Services offered
      • 16.2.1.3 Recent developments
        • 16.2.1.3.1 Product launches
      • 16.2.1.4 MnM view
    • 16.2.2 PENDULUM THERAPEUTICS
      • 16.2.2.1 Business overview
      • 16.2.2.2 Products/Solutions/Services offered
      • 16.2.2.3 Recent developments
        • 16.2.2.3.1 Product launches
        • 16.2.2.3.2 Deals
      • 16.2.2.4 MnM view
    • 16.2.3 FLORE INC.
      • 16.2.3.1 Business overview
      • 16.2.3.2 Products/Solutions/Services offered
      • 16.2.3.3 Recent developments
      • 16.2.3.4 MnM view
    • 16.2.4 CUSTOM PROBIOTICS INC.
      • 16.2.4.1 Business overview
      • 16.2.4.2 Products/Solutions/Services offered
      • 16.2.4.3 Recent developments
      • 16.2.4.4 MnM view
    • 16.2.5 ORA ORGANIC
      • 16.2.5.1 Business overview
      • 16.2.5.2 Products/Solutions/Services offered
      • 16.2.5.3 Recent developments
      • 16.2.5.4 MnM view
    • 16.2.6 LOVEBUG PROBIOTICS
    • 16.2.7 BIOHM HEALTH
    • 16.2.8 TONIIQ
    • 16.2.9 FITBIOMICS
    • 16.2.10 RESBIOTIC NUTRITION

17 RESEARCH METHODOLOGY

  • 17.1 RESEARCH DATA
    • 17.1.1 SECONDARY DATA
      • 17.1.1.1 Key data from secondary sources
    • 17.1.2 PRIMARY DATA
      • 17.1.2.1 Key data from primary sources
      • 17.1.2.2 Breakdown of primary profiles
      • 17.1.2.3 Key insights from industry experts
  • 17.2 MARKET SIZE ESTIMATION
    • 17.2.1 SUPPLY SIDE
  • 17.3 DATA TRIANGULATION
  • 17.4 RESEARCH ASSUMPTIONS
  • 17.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT

18 ADJACENT & RELATED MARKETS

  • 18.1 INTRODUCTION
  • 18.2 LIMITATIONS
  • 18.3 NUTRACEUTICAL INGREDIENTS MARKET
    • 18.3.1 MARKET DEFINITION
    • 18.3.2 MARKET OVERVIEW
  • 18.4 PROBIOTICS MARKET
    • 18.4.1 MARKET DEFINITION
    • 18.4.2 MARKET OVERVIEW

19 APPENDIX

  • 19.1 DISCUSSION GUIDE
  • 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 19.3 CUSTOMIZATION OPTIONS
  • 19.4 RELATED REPORTS
  • 19.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 USD EXCHANGE RATES, 2020-2024
  • TABLE 2 IMPACT OF PORTER'S FIVE FORCES ON PROBIOTIC SUPPLEMENTS MARKET
  • TABLE 3 ROLES OF COMPANIES IN PROBIOTIC SUPPLEMENTS MARKET ECOSYSTEM
  • TABLE 4 IMPORT DATA RELATED TO HS CODE 300490-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2025-2023 (KG)
  • TABLE 5 EXPORT DATA RELATED TO HS CODE 300490-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2025-2023 (KG)
  • TABLE 6 PROBIOTIC SUPPLEMENTS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026-2027
  • TABLE 7 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 8 TOP USE CASES AND MARKET POTENTIAL
  • TABLE 9 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
  • TABLE 10 PROBIOTIC SUPPLEMENTS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
  • TABLE 11 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 GLOBAL INDUSTRY STANDARDS IN PROBIOTIC SUPPLEMENTS MARKET
  • TABLE 18 DOCUMENTATION REQUIREMENTS AND CLAIMS IN PROBIOTIC SUPPLEMENTS MARKET
  • TABLE 19 CERTIFICATIONS, ACCREDITATION, AND ECO-STANDARDS IN PROBIOTIC SUPPLEMENTS MARKET
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT FORMAT
  • TABLE 21 KEY BUYING CRITERIA, BY PRODUCT FORMAT
  • TABLE 22 UNMET NEEDS IN PROBIOTIC SUPPLEMENTS MARKET, BY END-USE APPLICATION
  • TABLE 23 COST DYNAMICS IN PROBIOTIC SUPPLEMENTS MARKET
  • TABLE 24 MARGIN OPPORTUNITIES IN PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORMAT
  • TABLE 25 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 26 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 27 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (TONS)
  • TABLE 28 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (TONS)
  • TABLE 29 TABLETS & SOFTGELS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 30 TABLETS & SOFTGELS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 31 CAPSULES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 32 CAPSULES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 33 POWDER: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 34 POWDER: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 35 GUMMIES & CHEWABLES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 36 GUMMIES & CHEWABLES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 37 LIQUID: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 38 LIQUID: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 39 OTHER PRODUCT FORMS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 40 OTHER PRODUCT FORMS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 41 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 42 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 43 HYPERMARKETS/SUPERMARKETS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 44 HYPERMARKETS/SUPERMARKETS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 45 PHARMACIES/DRUGSTORES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 46 PHARMACIES/DRUGSTORES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 47 SPECIALTY STORES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 48 SPECIALTY STORES: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 49 E-COMMERCE: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 50 E-COMMERCE: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 51 OTHER DISTRIBUTION CHANNELS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 52 OTHER DISTRIBUTION CHANNELS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 53 PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2022-2025 (USD MILLION)
  • TABLE 54 PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026-2031 (USD MILLION)
  • TABLE 55 INFANTS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 56 INFANTS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 57 CHILDREN: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 58 CHILDREN: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 59 ADULTS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 60 ADULTS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 61 GERIATRIC POPULATION: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 62 GERIATRIC POPULATION: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 63 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 64 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 65 DIGESTIVE HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 66 DIGESTIVE HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 67 IMMUNITY SUPPORT: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 68 IMMUNITY SUPPORT: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 69 WOMEN'S HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 70 WOMEN'S HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 71 METABOLIC HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 72 METABOLIC HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 73 ORAL HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 74 ORAL HEALTH: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 75 OTHER HEALTH APPLICATIONS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 76 OTHER HEALTH APPLICATIONS: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 77 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022-2025 (USD MILLION)
  • TABLE 78 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026-2031 (USD MILLION)
  • TABLE 79 BACTERIA: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 80 BACTERIA: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 81 YEAST: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 82 YEAST: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 83 PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 84 PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 85 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 86 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 87 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 88 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 89 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 90 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 91 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (TONS)
  • TABLE 92 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (TONS)
  • TABLE 93 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 94 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 95 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2022-2025 (USD MILLION)
  • TABLE 96 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026-2031 (USD MILLION)
  • TABLE 97 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022-2025 (USD MILLION)
  • TABLE 98 NORTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026-2031 (USD MILLION)
  • TABLE 99 US: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 100 US: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 101 US: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 102 US: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 103 CANADA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 104 CANADA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 105 CANADA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 106 CANADA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 107 MEXICO: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 108 MEXICO: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 109 MEXICO: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 110 MEXICO: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 111 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 112 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 113 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 114 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 115 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 116 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 117 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (TONS)
  • TABLE 118 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (TONS)
  • TABLE 119 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 120 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 121 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2022-2025 (USD MILLION)
  • TABLE 122 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026-2031 (USD MILLION)
  • TABLE 123 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022-2025 (USD MILLION)
  • TABLE 124 EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026-2031 (USD MILLION)
  • TABLE 125 GERMANY: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 126 GERMANY: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 127 GERMANY: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 128 GERMANY: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 129 UK: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 130 UK: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 131 UK: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 132 UK: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 133 FRANCE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 134 FRANCE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 135 FRANCE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 136 FRANCE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 137 SPAIN: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 138 SPAIN: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 139 SPAIN: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 140 SPAIN: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 141 ITALY: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 142 ITALY: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 143 ITALY: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 144 ITALY: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 145 REST OF EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 146 REST OF EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 147 REST OF EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 148 REST OF EUROPE: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (TONS)
  • TABLE 156 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (TONS)
  • TABLE 157 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2022-2025 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026-2031 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022-2025 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026-2031 (USD MILLION)
  • TABLE 163 CHINA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 164 CHINA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 165 CHINA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 166 CHINA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 167 JAPAN: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 168 JAPAN: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 169 JAPAN: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 170 JAPAN: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 171 SOUTH KOREA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 172 SOUTH KOREA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 173 SOUTH KOREA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 174 SOUTH KOREA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 175 INDIA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 176 INDIA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 177 INDIA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 178 INDIA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 179 AUSTRALIA & NEW ZEALAND: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 180 AUSTRALIA & NEW ZEALAND: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 181 AUSTRALIA & NEW ZEALAND: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 182 AUSTRALIA & NEW ZEALAND: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 183 REST OF ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 184 REST OF ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 185 REST OF ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 186 REST OF ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 187 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 188 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 189 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 190 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 191 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 192 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 193 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (TONS)
  • TABLE 194 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (TONS)
  • TABLE 195 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 196 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 197 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2022-2025 (USD MILLION)
  • TABLE 198 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026-2031 (USD MILLION)
  • TABLE 199 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022-2025 (USD MILLION)
  • TABLE 200 SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026-2031 (USD MILLION)
  • TABLE 201 BRAZIL: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 202 BRAZIL: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 203 BRAZIL: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 204 BRAZIL: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 205 ARGENTINA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 206 ARGENTINA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 207 ARGENTINA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 208 ARGENTINA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 209 REST OF SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 210 REST OF SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 211 REST OF SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 212 REST OF SOUTH AMERICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 213 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 214 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 215 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 216 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 217 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 218 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 219 ROW: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (TONS)
  • TABLE 220 ROW: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (TONS)
  • TABLE 221 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 222 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 223 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2022-2025 (USD MILLION)
  • TABLE 224 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026-2031 (USD MILLION)
  • TABLE 225 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022-2025 (USD MILLION)
  • TABLE 226 REST OF THE WORLD: PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026-2031 (USD MILLION)
  • TABLE 227 MIDDLE EAST: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 228 MIDDLE EAST: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 229 MIDDLE EAST: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 230 MIDDLE EAST: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 231 AFRICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2022-2025 (USD MILLION)
  • TABLE 232 AFRICA: PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026-2031 (USD MILLION)
  • TABLE 233 AFRICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 234 AFRICA: PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 235 OVERVIEW OF STRATEGIES ADOPTED BY KEY PROBIOTIC SUPPLEMENTS VENDORS, 2020-2026
  • TABLE 236 PROBIOTIC SUPPLEMENTS MARKET: DEGREE OF COMPETITION
  • TABLE 237 PROBIOTIC SUPPLEMENTS MARKET: REGION FOOTPRINT
  • TABLE 238 PROBIOTIC SUPPLEMENTS MARKET: HEALTH APPLICATION FOOTPRINT
  • TABLE 239 PROBIOTIC SUPPLEMENTS S MARKET: PRODUCT FORM FOOTPRINT
  • TABLE 240 PROBIOTIC SUPPLEMENTS S MARKET: END USER FOOTPRINT
  • TABLE 241 PROBIOTIC SUPPLEMENTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025
  • TABLE 242 PROBIOTIC SUPPLEMENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 243 PROBIOTIC SUPPLEMENTS MARKET: PRODUCT LAUNCHES, 2020-MAY 2026
  • TABLE 244 PROBIOTIC SUPPLEMENTS MARKET: DEALS, 2020-MAY 2026
  • TABLE 245 PROBIOTIC SUPPLEMENTS MARKET: EXPANSIONS, JANUARY 2022-APRIL 2026
  • TABLE 246 NESTLE S.A.: COMPANY OVERVIEW
  • TABLE 247 NESTLE S.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 248 NESTLE S.A.: DEALS
  • TABLE 249 YAKULT HONSHA CO., LTD.: COMPANY OVERVIEW
  • TABLE 250 YAKULT HONSHA CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 251 YAKULT HONSHA CO., LTD.: PRODUCT LAUNCHES
  • TABLE 252 YAKULT HONSHA CO., LTD.: DEALS
  • TABLE 253 BIOGAIA: COMPANY OVERVIEW
  • TABLE 254 BIOGAIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 255 BIOGAIA: PRODUCT LAUNCHES
  • TABLE 256 BIOGAIA: DEALS
  • TABLE 257 KERRY GROUP PLC: COMPANY OVERVIEW
  • TABLE 258 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 259 KERRY GROUP PLC: DEALS
  • TABLE 260 AMWAY: COMPANY OVERVIEW
  • TABLE 261 AMWAY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 262 AMWAY: PRODUCT LAUNCHES
  • TABLE 263 NATURE'S WAY: COMPANY OVERVIEW
  • TABLE 264 NATURE'S WAY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 265 NATURE'S WAY: EXPANSIONS
  • TABLE 266 HERBALIFE LTD.: COMPANY OVERVIEW
  • TABLE 267 HERBALIFE LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 268 HERBALIFE LTD.: DEALS
  • TABLE 269 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY OVERVIEW
  • TABLE 270 MORINAGA MILK INDUSTRY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 271 MORINAGA MILK INDUSTRY CO., LTD.: DEALS
  • TABLE 272 JARROW FORMULAS, INC.: COMPANY OVERVIEW
  • TABLE 273 JARROW FORMULAS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 274 JARROW FORMULAS, INC.: PRODUCT LAUNCHES
  • TABLE 275 JARROW FORMULAS, INC.: DEALS
  • TABLE 276 SYMRISE AG: COMPANY OVERVIEW
  • TABLE 277 SYMRISE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 278 SYMRISE AG: PRODUCT LAUNCHES
  • TABLE 279 METAGENICS, INC.: BUSINESS OVERVIEW
  • TABLE 280 METAGENICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 281 METAGENICS, INC.: DEALS
  • TABLE 282 OPTIBIOTIX HEALTH PLC: COMPANY OVERVIEW
  • TABLE 283 OPTIBIOTIX HEALTH PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 284 OPTIBAC PROBIOTICS LTD.: COMPANY OVERVIEW
  • TABLE 285 OPTIBAC PROBIOTICS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 286 OPTIBAC PROBIOTICS LTD.: PRODUCT LAUNCHES
  • TABLE 287 AB-BIOTICS S.A.: COMPANY OVERVIEW
  • TABLE 288 AB-BIOTICS S.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 289 AB-BIOTICS S.A.: DEALS
  • TABLE 290 LIFEWAY FOODS, INC.: COMPANY OVERVIEW
  • TABLE 291 LIFEWAY FOODS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 292 SEED HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 293 SEED HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 294 SEED HEALTH, INC.: PRODUCT LAUNCHES
  • TABLE 295 PENDULUM THERAPEUTICS: COMPANY OVERVIEW
  • TABLE 296 PENDULUM THERAPEUTICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 297 PENDULUM THERAPEUTICS: PRODUCT LAUNCHES
  • TABLE 298 PENDULUM THERAPEUTICS: DEALS
  • TABLE 299 FLORE INC.: COMPANY OVERVIEW
  • TABLE 300 FLORE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 301 CUSTOM PROBIOTICS INC.: COMPANY OVERVIEW
  • TABLE 302 CUSTOM PROBIOTICS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 303 ORA ORGANIC: COMPANY OVERVIEW
  • TABLE 304 ORA ORGANIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 305 LOVEBUG PROBIOTICS: BUSINESS OVERVIEW
  • TABLE 306 BIOHM HEALTH: BUSINESS OVERVIEW
  • TABLE 307 TONIIQ: BUSINESS OVERVIEW
  • TABLE 308 FITBIOMICS: BUSINESS OVERVIEW
  • TABLE 309 RESBIOTIC NUTRITION: BUSINESS OVERVIEW
  • TABLE 310 ADJACENT MARKETS TO PROBIOTIC SUPPLEMENTS MARKET
  • TABLE 311 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 312 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 313 PROBIOTICS MARKET, BY REGION, 2020-2023 (USD BILLION)
  • TABLE 314 PROBIOTICS MARKET, BY REGION, 2024-2029 (USD BILLION)

List of Figures

  • FIGURE 1 MARKET SCENARIO
  • FIGURE 2 PROBIOTIC SUPPLEMENTS MARKET, 2022-2031
  • FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PROBIOTIC SUPPLEMENTS MARKET, 2020-JANUARY 2026
  • FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF PROBIOTIC SUPPLEMENTS MARKET
  • FIGURE 5 HIGH-GROWTH SEGMENTS IN PROBIOTIC SUPPLEMENTS MARKET, 2026-2031
  • FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 7 RISING CONSUMER FOCUS ON GUT HEALTH, IMMUNITY, AND PREVENTIVE HEALTHCARE TO DRIVE MARKET
  • FIGURE 8 CAPSULES SEGMENT AND ASIA PACIFIC TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026
  • FIGURE 9 BACTERIA SEGMENT TO DOMINATE MARKET IN 2026
  • FIGURE 10 E-COMMERCE SEGMENT TO LEAD MARKET IN 2026
  • FIGURE 11 ADULTS SEGMENT TO DOMINATE MARKET IN 2026
  • FIGURE 12 DIGESTIVE & GUT HEALTH SEGMENT TO DOMINATE MARKET IN 2026
  • FIGURE 13 US TO LEAD MARKET IN 2026
  • FIGURE 14 PROBIOTIC SUPPLEMENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15 PROBIOTIC SUPPLEMENTS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 16 WORLD POPULATION, BY ECONOMY, 1950-2050
  • FIGURE 17 POPULATION GROWTH TREND, 1950-2050
  • FIGURE 18 PROBIOTIC SUPPLEMENTS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 19 PROBIOTIC SUPPLEMENTS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 20 AVERAGE SELLING PRICE OF PROBIOTIC SUPPLEMENTS OFFERED BY KEY PLAYERS, BY PRODUCT FORM, 2025 (USD/KG)
  • FIGURE 21 AVERAGE SELLING PRICE OF PROBIOTIC SUPPLEMENTS, BY REGION, 2021-2025 (USD/KG)
  • FIGURE 22 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS
  • FIGURE 23 INVESTMENT AND FUNDING SCENARIO, 2025
  • FIGURE 24 PATENTS APPLIED AND GRANTED, MAY 2016-MAY 2026
  • FIGURE 25 FUTURE APPLICATIONS
  • FIGURE 26 PROBIOTIC SUPPLEMENTS MARKET DECISION-MAKING FACTORS
  • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT FORMAT
  • FIGURE 28 KEY BUYING CRITERIA, BY PRODUCT FORMAT
  • FIGURE 29 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • FIGURE 30 PROBIOTIC SUPPLEMENTS MARKET, BY PRODUCT FORM, 2026 VS. 2031 (USD MILLION)
  • FIGURE 31 PROBIOTIC SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2026 VS. 2031 (USD MILLION)
  • FIGURE 32 PROBIOTIC SUPPLEMENTS MARKET, BY END USER, 2026 VS. 2031 (USD MILLION)
  • FIGURE 33 PROBIOTIC SUPPLEMENTS MARKET, BY HEALTH APPLICATION, 2026 VS. 2031 (USD MILLION)
  • FIGURE 34 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026 VS. 2031 (USD MILLION)
  • FIGURE 35 PROBIOTIC SUPPLEMENTS MARKET GROWTH, BY KEY COUNTRY, 2026-2031
  • FIGURE 36 EUROPE: PROBIOTIC SUPPLEMENTS MARKET SNAPSHOT
  • FIGURE 37 ASIA PACIFIC: PROBIOTIC SUPPLEMENTS MARKET SNAPSHOT
  • FIGURE 38 PROBIOTIC SUPPLEMENTS MARKET: REVENUE ANALYSIS, 2023-2025 (USD BILLION)
  • FIGURE 39 SHARE ANALYSIS OF LEADING COMPANIES IN PROBIOTIC SUPPLEMENTS MARKET, 2025
  • FIGURE 40 COMPARATIVE ANALYSIS OF VENDOR BRANDS
  • FIGURE 41 PROBIOTIC SUPPLEMENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 42 PROBIOTIC SUPPLEMENTS MARKET: COMPANY FOOTPRINT
  • FIGURE 43 PROBIOTIC SUPPLEMENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 44 COMPANY VALUATION OF KEY PROBIOTIC SUPPLEMENTS VENDORS
  • FIGURE 45 EV/EBITDA OF KEY COMPANIES
  • FIGURE 46 NESTLE S.A.: COMPANY SNAPSHOT
  • FIGURE 47 YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 48 BIOGAIA: COMPANY SNAPSHOT
  • FIGURE 49 KERRY GROUP PLC: COMPANY SNAPSHOT
  • FIGURE 50 AMWAY: COMPANY SNAPSHOT
  • FIGURE 51 HERBALIFE LTD.: COMPANY SNAPSHOT
  • FIGURE 52 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 53 SYMRISE AG: COMPANY SNAPSHOT
  • FIGURE 54 OPTIBIOTIX HEALTH PLC: COMPANY SNAPSHOT
  • FIGURE 55 LIFEWAY FOODS, INC.: COMPANY SNAPSHOT
  • FIGURE 56 PROBIOTIC SUPPLEMENTS MARKET: RESEARCH DESIGN
  • FIGURE 57 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 58 KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 59 BOTTOM-UP APPROACH (BASED ON DISTRIBUTION CHANNEL, BY REGION)
  • FIGURE 60 TOP-DOWN APPROACH - FROM PARENT MARKET
  • FIGURE 61 PROBIOTIC SUPPLEMENTS MARKET: SUPPLY SIDE ANALYSIS
  • FIGURE 62 DATA TRIANGULATION: SUPPLY SIDE
  • FIGURE 63 DATA TRIANGULATION METHODOLOGY